Patients with significantly elevated or diminished BMI may exhibit a variety of health consequences, including metabolic and endocrine alterations, as well as decreased fecundity. The reproductive impact of elevated BMI has been well studied, but few studies have convincingly quantified the effects of low BMI on oocyte and embryo quality and implantation efficacy. Patients with low BMI are known to be at risk for alterations in steroid metabolism, insulin secretion, and changes in other hormones, including ghrelin, leptin, and adiponectin.
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1-6 The current study aimed to determine the impact of low BMI on ovarian response to controlled ovarian stimulation (COS) for IVF.
Design:
Retrospective cohort study
Material and Methods:
This 
Results:
A total of 571 underweight women and 9,220 normal weight women's IVF cycles were identified. Underweight patients were younger (35.3 ± 5.1 yrs, p<0.0001), had a higher AMH (3.2 ± 4.3 ng/mL, p = 0.02), BAFC (11.9 ± 6.6, p<0.0001), E2 (2279 ± 1175 pg/mL, p<0.0001) and P4 (0.99 ± 1.1 ng/mL, p<0.0001) level at time of surge, but lower cumulative GND dose (3572 ± 1559 IU, p<0.001) than women with a normal BMI. Underweight patients also were more likely to be treated with an antagonist stimulation protocol (65%, p=0.04) as compared to normal weight patients. Gravidity, parity and type of trigger used were similar between groups. While the number of MII oocytes (11.3 ± 8.1, p<0.002) and fertilized oocytes (8.3 ± 6.6, p<0.01) were greater in underweight compared to normal weight women, the MII and fertilization rates did not differ between groups, before and after adjusting for confounders. Blastulation and euploidy rates were not significantly different between BMI groups after accounting for significant covariates.
Conclusions:
Extreme alterations in body composition and decreased energy availability associated with a low BMI may result in serious health consequences, yet in this large single center study, we demonstrate that ART outcome is not affected. With IVF utilization, underweight women can overcome the detrimental effects of ovulatory dysfunction associated with a low BMI and achieve successful reproductive outcomes. While this study provides reassurance to underweight patients undergoing IVF, providers are encouraged to focus on discussing nutritional and exercise guidelines that may optimize pre-conception health.
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